-
HER2/neu: an increasingly important therapeutic target. Part 3: clinical applications and investigations
Edward L Nelson
Clinical Trail Outcomes: Clinical Investigation
-
HER2/neu: an increasingly important therapeutic target. Part 3: clinical applications and investigations
Edward L Nelson
Clinical Trail Outcomes: Clinical Investigation
-
HER2/neu: an increasingly important therapeutic target. Part 3: clinical applications and investigations
Edward L Nelson
Clinical Trail Outcomes: Clinical Investigation
-
HER2/neu: an increasingly important therapeutic target. Part 3: clinical applications and investigations
Edward L Nelson
Clinical Trail Outcomes: Clinical Investigation
-
HER2/neu: an increasingly important therapeutic target. Part 3: clinical applications and investigations
Edward L Nelson
Clinical Trail Outcomes: Clinical Investigation
-
HER2/neu: an increasingly important therapeutic target. Part 3: clinical applications and investigations
Edward L Nelson
Clinical Trail Outcomes: Clinical Investigation
-
HER2/neu: an increasingly important therapeutic target. Part 3: clinical applications and investigations
Edward L Nelson
Clinical Trail Outcomes: Clinical Investigation
-
HER2/neu: an increasingly important therapeutic target. Part 3: clinical applications and investigations
Edward L Nelson
Clinical Trail Outcomes: Clinical Investigation
-
An update of adjuvant treatments for localized advanced gastric cancer
Yoon-Koo Kang
Review Article: Clinical Investigation
-
An update of adjuvant treatments for localized advanced gastric cancer
Yoon-Koo Kang
Review Article: Clinical Investigation
-
An update of adjuvant treatments for localized advanced gastric cancer
Yoon-Koo Kang
Review Article: Clinical Investigation
-
An update of adjuvant treatments for localized advanced gastric cancer
Yoon-Koo Kang
Review Article: Clinical Investigation
-
An update of adjuvant treatments for localized advanced gastric cancer
Yoon-Koo Kang
Review Article: Clinical Investigation
-
An update of adjuvant treatments for localized advanced gastric cancer
Yoon-Koo Kang
Review Article: Clinical Investigation
-
An update of adjuvant treatments for localized advanced gastric cancer
Yoon-Koo Kang
Review Article: Clinical Investigation
-
An update of adjuvant treatments for localized advanced gastric cancer
Yoon-Koo Kang
Review Article: Clinical Investigation
-
Assessing health-related quality of life in cancer trials
Roxanne E Jensen, Carol M Moinpour, Diane L Fairclough
Clinical Trail Perspective: Clinical Investigation
-
Assessing health-related quality of life in cancer trials
Roxanne E Jensen, Carol M Moinpour, Diane L Fairclough
Clinical Trail Perspective: Clinical Investigation
-
Assessing health-related quality of life in cancer trials
Roxanne E Jensen, Carol M Moinpour, Diane L Fairclough
Clinical Trail Perspective: Clinical Investigation
-
Assessing health-related quality of life in cancer trials
Roxanne E Jensen, Carol M Moinpour, Diane L Fairclough
Clinical Trail Perspective: Clinical Investigation
-
Assessing health-related quality of life in cancer trials
Roxanne E Jensen, Carol M Moinpour, Diane L Fairclough
Clinical Trail Perspective: Clinical Investigation
-
Assessing health-related quality of life in cancer trials
Roxanne E Jensen, Carol M Moinpour, Diane L Fairclough
Clinical Trail Perspective: Clinical Investigation
-
Assessing health-related quality of life in cancer trials
Roxanne E Jensen, Carol M Moinpour, Diane L Fairclough
Clinical Trail Perspective: Clinical Investigation
-
Assessing health-related quality of life in cancer trials
Roxanne E Jensen, Carol M Moinpour, Diane L Fairclough
Clinical Trail Perspective: Clinical Investigation
-
IL-17 in systemic lupus erythematosus
Wu Qian, Antonio La Cava
Review: Clinical Trail Outcomes: Clinical Investigation
-
IL-17 in systemic lupus erythematosus
Wu Qian, Antonio La Cava
Review: Clinical Trail Outcomes: Clinical Investigation
-
IL-17 in systemic lupus erythematosus
Wu Qian, Antonio La Cava
Review: Clinical Trail Outcomes: Clinical Investigation
-
IL-17 in systemic lupus erythematosus
Wu Qian, Antonio La Cava
Review: Clinical Trail Outcomes: Clinical Investigation
-
IL-17 in systemic lupus erythematosus
Wu Qian, Antonio La Cava
Review: Clinical Trail Outcomes: Clinical Investigation
-
IL-17 in systemic lupus erythematosus
Wu Qian, Antonio La Cava
Review: Clinical Trail Outcomes: Clinical Investigation
-
IL-17 in systemic lupus erythematosus
Wu Qian, Antonio La Cava
Review: Clinical Trail Outcomes: Clinical Investigation
-
IL-17 in systemic lupus erythematosus
Wu Qian, Antonio La Cava
Review: Clinical Trail Outcomes: Clinical Investigation
-
BRAF-targeted therapy for metastatic melanoma: rationale, clinical activity and safety
Rahat Noor, Van A Trinh, Kevin B Kim, Wen-Jen Hwu
Review Article: Clinical Investigation
-
BRAF-targeted therapy for metastatic melanoma: rationale, clinical activity and safety
Rahat Noor, Van A Trinh, Kevin B Kim, Wen-Jen Hwu
Review Article: Clinical Investigation
-
BRAF-targeted therapy for metastatic melanoma: rationale, clinical activity and safety
Rahat Noor, Van A Trinh, Kevin B Kim, Wen-Jen Hwu
Review Article: Clinical Investigation
-
BRAF-targeted therapy for metastatic melanoma: rationale, clinical activity and safety
Rahat Noor, Van A Trinh, Kevin B Kim, Wen-Jen Hwu
Review Article: Clinical Investigation
-
BRAF-targeted therapy for metastatic melanoma: rationale, clinical activity and safety
Rahat Noor, Van A Trinh, Kevin B Kim, Wen-Jen Hwu
Review Article: Clinical Investigation
-
BRAF-targeted therapy for metastatic melanoma: rationale, clinical activity and safety
Rahat Noor, Van A Trinh, Kevin B Kim, Wen-Jen Hwu
Review Article: Clinical Investigation
-
BRAF-targeted therapy for metastatic melanoma: rationale, clinical activity and safety
Rahat Noor, Van A Trinh, Kevin B Kim, Wen-Jen Hwu
Review Article: Clinical Investigation
-
BRAF-targeted therapy for metastatic melanoma: rationale, clinical activity and safety
Rahat Noor, Van A Trinh, Kevin B Kim, Wen-Jen Hwu
Review Article: Clinical Investigation